Skip to content

Clinical study on intervention scheme of lumbar disc herniation based on clinical practice

Clinical study on intervention scheme of lumbar disc herniation based on clinical practice

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058598
Enrollment
Unknown
Registered
2022-04-12
Start date
2022-04-12
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Manipulation plus acupuncture group:Ten step manipulation of ''point, pull and shake'' combined with acupuncture
Manipulation group:Ten step manipulation of ''point, pull and shake''
Acupuncture group:Acupuncture
Rehabilitation exercise group:Core muscle rehabilitation exercises

Sponsors

Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Test 1: (1) No gender limit, aged 18-59 years, with reference to the United Nations World Health Organization's standards for young and middle-aged people. (2) Patients with typical clinical symptoms of lumbago, definite diagnosis of lumbar disc herniation and meeting the diagnostic criteria. (3) Patients who can accept the experimental method to cooperate with treatment, fully volunteer to cooperate with follow-up, and sign informed consent. 2. Test 2: (1) No gender limit, aged 18-59 years. (2) Patients with typical clinical symptoms of low back pain who failed to respond to strict conservative treatment and were clearly diagnosed by CT or MRI. (3) The patients who successfully and actively cooperated with the patients who completed the nucleus pulposus extraction under the foraminoscope, and the operative method was clear and single. (4) Patients who cooperated with the postoperative treatment, completed the training on time and according to the amount under the guidance, and fully volunteered to cooperate with the follow-up. (5) Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Test 1: (1) Obvious osseous hyperplasia combined with severe lumbar spinal stenosis, lumbar spondylolisthesis or spondylolysis. (2) Cauda equina syndrome, myelconus syndrome and other absolute surgical indications. (3) Patients with tuberculosis or tumor of lumbar spine. (4) Patients with severe osteoporosis. (5) Patients with heart, brain, liver, kidney, hematopoietic system and other primary diseases, genetic diseases, severe trauma, infectious diseases, or mental diseases can not cooperate to complete the test. (6) Patients with severe skin injury, infection or skin disease at the treatment site. 2. Test 2: (1) Patients who failed to successfully complete the excision of lumbar disc herniation nucleus pulposus under foraminal microscope. (2) Patients with heart, brain, liver, kidney, hematopoietic system and other primary diseases, genetic diseases, severe trauma, infectious diseases, or mental diseases can not cooperate to complete the test. (3) Patients with tuberculosis or tumor of lumbar spine. (4) Obvious osseous hyperplasia combined with severe lumbar spinal stenosis, lumbar spondylolisthesis or vertebral arch stenosis. (5) Patients with other serious diseases or surgical treatment after foraminoscopy that seriously affected the quality of life.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale Score;Japanese Orthopaedic Association Scores;Oswestry Dability Index;Medical Outcomes Study;

Secondary

MeasureTime frame
Lumbar MRI;

Countries

China

Contacts

Public ContactZhang Shimin

Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine Sciences

Smzhang1117@163.com+86 13601326191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026